Cardiology

Cardiology Expert Witness

Cardiology expert witnesses evaluate disputes involving the diagnosis and nonsurgical management of heart disease, including coronary artery disease, heart failure, arrhythmias, valvular disease, and vascular conditions. Cardiology malpractice claims commonly arise from missed myocardial infarctions, delayed intervention for acute coronary syndromes, inappropriate anticoagulation management, or failure to diagnose life-threatening arrhythmias from available ECG and telemetry data. Attorneys rely on cardiology experts to review diagnostic studies, pharmacologic management, and interventional cardiology procedures and to explain whether the cardiologist's decisions aligned with evidence-based guidelines.

When your case involves a patient who presented to an emergency department with atypical chest pain and a nondiagnostic initial troponin level but was discharged without serial troponin testing or stress evaluation, only to suffer a fatal STEMI within hours, a cardiology expert can explain why the failure to apply ACS risk stratification tools and observation protocols deviated from the standard of care. If a patient on warfarin for atrial fibrillation suffered a massive ischemic stroke because the cardiologist failed to monitor INR levels or transition to a direct oral anticoagulant despite labile INR values, the expert evaluates whether anticoagulation management met ACC/AHA guidelines. In cases where a patient underwent a cardiac catheterization and developed a coronary artery dissection or perforation during percutaneous coronary intervention, the expert assesses whether the interventional technique, lesion selection, and complication management were appropriate. When a patient with known hypertrophic cardiomyopathy dies suddenly during athletic activity because the cardiologist cleared them for sports participation without adequate risk stratification, the expert can explain the screening and restriction guidelines that should have been applied. For damages testimony, the expert projects the long-term cardiac consequences of delayed diagnosis — including permanent reduction in left ventricular ejection fraction after missed myocardial infarction, the need for implantable cardioverter-defibrillator placement and lifetime device management, reduced life expectancy calculated using the Seattle Heart Failure Model, and permanent activity restrictions affecting vocational capacity — providing the foundation for a life care plan or damages calculation. The expert quantifies the lifetime cost of guideline-directed heart failure pharmacotherapy, cardiac rehabilitation programs, repeat catheterization procedures, and the economic impact of functional limitations measured by metabolic equivalents on stress testing.

A cardiology expert witness evaluates the interpretation of electrocardiograms, echocardiograms, stress tests, Holter monitors, cardiac catheterization images, and cardiac MRI or CT angiography. They assess whether diagnostic workups were appropriately ordered and correctly interpreted — for example, whether a borderline troponin should have prompted serial testing, or whether an echocardiographic finding of moderate aortic stenosis warranted closer surveillance. The expert reviews pharmacologic management including anticoagulant selection, heart failure medication titration per GDMT protocols, antiarrhythmic drug monitoring, and appropriate use of implantable devices such as pacemakers and ICDs. For interventional cases, the expert evaluates stent selection, access site management, procedural technique, and complication recognition. They also assess whether noninvasive options were exhausted before invasive procedures and whether shared decision-making was documented. Anchor Medical Expert Consulting connects attorneys with practicing cardiologists across all subspecialties — interventional, electrophysiology, heart failure, and preventive cardiology — to ensure precise alignment between the clinical issues in the case and the expert's actual practice. For long-term prognosis and damages analysis, the expert evaluates permanent cardiac impairment using serial echocardiographic ejection fraction, exercise capacity measured in METs on stress testing, and NYHA functional class progression. They project lifetime costs of heart failure pharmacotherapy (sacubitril-valsartan, beta-blockers, mineralocorticoid receptor antagonists, SGLT2 inhibitors), implantable device management including generator replacements every 5–7 years, and cardiac rehabilitation. The expert calculates reduced life expectancy using validated heart failure prognostic models and assesses vocational disability using AMA Guides impairment ratings indexed to cardiac functional capacity.